Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2019-05-15
2021-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Pococyturia and Pre-eclampsia Severity
NCT03316391
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
NCT00930397
First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography
NCT03342014
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients coming before 16 weeks of gestation at their first planned prenatal visit at the Hôpital Femme Mère Enfant, who planned to deliver at the Hôpital Femme Mère Enfant
Podocyturia quantification
Podocyturia quantification at first planned prenatal care visit before 16 weeks of gestation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Podocyturia quantification
Podocyturia quantification at first planned prenatal care visit before 16 weeks of gestation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* single pregnancy
* first planned prenatal visit before 16 weeks of gestation
* planned delivery at Hôpital Femme Mère Enfant in Lyon, France
* patient receiving information and non opposition to participate
Exclusion Criteria
* pregnancy stopped
* antecedent of nephropathy
* inability to understand information provided
* prisoner or under administrative supervision
* fetal malformation, chromosomal anomalies
* preterm delivery for other reason that any hypertensive disorder of pregnancy or Intrauterine growth restriction
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL17_0516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.